Cardiol Therapeutics (CRDL) Prepaid Assets (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Prepaid Assets of $2.4 million for Q1 2026, up 78.04% on a QoQ basis from $1.3 million in Q4 2025, and up 108.55% year-over-year from $1.1 million in Q1 2025.
Cardiol Therapeutics (CRDL) Prepaid Assets (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- Quarterly Prepaid Assets rose 108.55% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 108.55% YoY) and the FY2025 annual result came in at $1.3 million, up 156.32% from the prior year.
- Prepaid Assets was $2.4 million for Q1 2026 at Cardiol Therapeutics, up from $1.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.4 million in Q1 2022 and bottomed at $520070.8 in Q4 2024.
- A 5-year average of $1.3 million and a median of $1.1 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 51.25% — and 2025, when it soared 156.32%.
- Cardiol Therapeutics' Prepaid Assets stood at $1.1 million in 2022, then sank by 36.91% to $691522.6 in 2023, then slipped by 24.79% to $520070.8 in 2024, then surged by 156.32% to $1.3 million in 2025, then jumped by 78.04% to $2.4 million in 2026.
- Business Quant data shows CRDL's Prepaid Assets at $2.4 million in Q1 2026, $1.3 million in Q4 2025, and $718302.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 718,301.95 |
| Jun 30, 2025 | 937,682.08 |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 520,070.84 |
| Sep 30, 2024 | 828,346.69 |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 691,522.60 |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 1.77 Mn |